In November 2018 diets were formulated for the first trials of SYLFEED. This includes two small-scale trials, the first with juvenile Atlantic Salmon and the second with Nile Tilapia. The two species have very different nutritional requirements since Atlantic Salmon is a carnivorous species and Nile Tilapia is an omnivorous species so unique diets must be formulated for each.
Matis has produced 10 feed treatments with various inclusion levels of SylPro replacing current protein sources used in commercial diets. Animal trials will start beginning of 2019.
